Live feed20:26:36·337dINSIDERFilingvia QuantisnowChief Financial Officer Steinhart Richard I was granted 4,375 shares and converted options into 625 shares, increasing direct ownership by 347% to 6,441 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.BTAI· BioXcel Therapeutics Inc.Health CareOriginal source